BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 28501799)

  • 1. High maternal expression of SIGLEC1 on monocytes as a surrogate marker of a type I interferon signature is a risk factor for the development of autoimmune congenital heart block.
    Lisney AR; Szelinski F; Reiter K; Burmester GR; Rose T; Dörner T
    Ann Rheum Dis; 2017 Aug; 76(8):1476-1480. PubMed ID: 28501799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I IFN system activation in newborns exposed to Ro/SSA and La/SSB autoantibodies in utero.
    Hedlund M; Thorlacius GE; Ivanchenko M; Ottosson V; Kyriakidis N; Lagnefeldt L; Tingström J; Sirsjö A; Bengtsson AA; Aronsson E; Gemzell-Danielsson K; Ronnblom L; Bergman G; Espinosa A; Sonesson SE; Eloranta ML; Wahren-Herlenius M
    RMD Open; 2020 Jan; 6(1):. PubMed ID: 31958275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.
    Martínez-Sánchez N; Pérez-Pinto S; Robles-Marhuenda Á; Arnalich-Fernández F; Martín Cameán M; Hueso Zalvide E; Bartha JL
    Immunol Res; 2017 Apr; 65(2):487-494. PubMed ID: 28138914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Siglec-1 Macrophages and the Contribution of IFN to the Development of Autoimmune Congenital Heart Block.
    Clancy RM; Halushka M; Rasmussen SE; Lhakhang T; Chang M; Buyon JP
    J Immunol; 2019 Jan; 202(1):48-55. PubMed ID: 30518570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
    Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F
    J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ro52, Ro60 and La IgG autoantibody levels and Ro52 IgG subclass profiles longitudinally throughout pregnancy in congenital heart block risk pregnancies.
    Strandberg L; Salomonsson S; Bremme K; Sonesson S; Wahren-Herlenius M
    Lupus; 2006; 15(6):346-53. PubMed ID: 16830880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal HLA antigens and antibodies to SS-A/Ro and SS-B/La. Comparison with systemic lupus erythematosus and primary Sjögren's syndrome.
    Julkunen H; Siren MK; Kaaja R; Kurki P; Friman C; Koskimies S
    Br J Rheumatol; 1995 Oct; 34(10):901-7. PubMed ID: 7582692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal autoantibodies and congenital heart block: no evidence for the existence of a unique heart block-associated anti-Ro/SS-A autoantibody profile.
    Meilof JF; Frohn-Mulder IM; Stewart PA; Szatmari A; Hess J; Veldhoven CH; Smeenk RJ; Swaak AJ
    Lupus; 1993 Aug; 2(4):239-46. PubMed ID: 7505695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significantly increased maternal and fetal IgG autoantibody levels to 52 kD Ro (SS-A) and La(SS-B) in complete congenital heart block.
    Dörner T; Chaoui R; Feist E; Göldner B; Yamamoto K; Hiepe F
    J Autoimmun; 1995 Oct; 8(5):675-84. PubMed ID: 8579723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block.
    Tseng CE; Caldwell K; Feit S; Chan EK; Buyon JP
    J Rheumatol; 1996 May; 23(5):925-32. PubMed ID: 8724310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cells and type II interferon in Ro/SSA and La/SSB autoantibody-exposed newborns at risk of congenital heart block.
    Ivanchenko M; Thorlacius GE; Hedlund M; Ottosson V; Meneghel L; Björkander S; Ossoinak A; Tingström J; Bremme K; Sverremark-Ekström E; Gemzell-Danielsson K; Sonesson SE; Chemin K; Wahren-Herlenius M
    Ann Rheum Dis; 2021 Feb; 80(2):194-202. PubMed ID: 33004330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Congenital heart block associated with maternal anti SSA/SSB antibodies :a report of four cases].
    Ayed K; Gorgi Y; Sfar I; Khrouf M
    Pathol Biol (Paris); 2004 Apr; 52(3):138-47. PubMed ID: 15063933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and anti-SS-B/La antibodies.
    Buyon JP; Winchester RJ; Slade SG; Arnett F; Copel J; Friedman D; Lockshin MD
    Arthritis Rheum; 1993 Sep; 36(9):1263-73. PubMed ID: 8216420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune response in mothers of children with congenital and postnatally diagnosed isolated heart block: a population based study.
    Julkunen H; Miettinen A; Walle TK; Chan EK; Eronen M
    J Rheumatol; 2004 Jan; 31(1):183-9. PubMed ID: 14705240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of heart block in children of SSA/SSB-autoantibody-positive women is associated with maternal age and displays a season-of-birth pattern.
    Ambrosi A; Salomonsson S; Eliasson H; Zeffer E; Skog A; Dzikaite V; Bergman G; Fernlund E; Tingström J; Theander E; Rydberg A; Skogh T; Öhman A; Lundström U; Mellander M; Winqvist O; Fored M; Ekbom A; Alfredsson L; Källberg H; Olsson T; Gadler F; Jonzon A; Kockum I; Sonesson SE; Wahren-Herlenius M
    Ann Rheum Dis; 2012 Mar; 71(3):334-40. PubMed ID: 21953338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of mothers of children with complete congenital heart block.
    Press J; Uziel Y; Laxer RM; Luy L; Hamilton RM; Silverman ED
    Am J Med; 1996 Mar; 100(3):328-32. PubMed ID: 8629679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects.
    Clancy RM; Buyon JP; Ikeda K; Nozawa K; Argyle DA; Friedman DM; Chan EK
    Arthritis Rheum; 2005 Oct; 52(10):3079-86. PubMed ID: 16200587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome in 212 anti-Ro/SSA-positive pregnancies and population-based incidence of congenital heart block.
    Skog A; Lagnefeldt L; Conner P; Wahren-Herlenius M; Sonesson SE
    Acta Obstet Gynecol Scand; 2016 Jan; 95(1):98-105. PubMed ID: 26411741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital heart block in neonatal lupus: the pediatric cardiologist's perspective.
    Friedman DM; Rupel A; Glickstein J; Buyon JP
    Indian J Pediatr; 2002 Jun; 69(6):517-22. PubMed ID: 12139139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal predictive factors for fetal congenital heart block in pregnant mothers positive for anti-SS-A antibodies.
    Tsuboi H; Sumida T; Noma H; Yamagishi K; Anami A; Fukushima K; Horigome H; Maeno Y; Kishimoto M; Takasaki Y; Nakayama M; Waguri M; Sago H; Murashima A
    Mod Rheumatol; 2016 Jul; 26(4):569-75. PubMed ID: 26457409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.